SELLAS Life Sciences posts $10.1M Q3 loss as pivotal leukemia trial results approach
SELLAS Life Sciences posts $10.1M Q3 loss as pivotal leukemia trial results approach
- Read at Crypto Briefing
- Thu, 12 Nov 2026 21:26:16 +0000
SELLAS Life Sciences posts $10.1M Q3 loss as pivotal leukemia trial results approach